Alexandra Rojek (@alexandrarojek) 's Twitter Profile
Alexandra Rojek

@alexandrarojek

Heme/Onc fellow @UCCancerCenter and @KlineLabUChi, interested in aggressive lymphomas and cellular therapy; @JCO_ASCO editorial fellow. Views are my own.

ID: 2486619043

calendar_today10-05-2014 03:45:37

325 Tweet

375 Followers

461 Following

University of Chicago Hem/Onc Fellows (@uchemoncfellows) 's Twitter Profile Photo

ASCO weekend this year means celebrating UChicagoCancerCenter’s 50th anniversary in style with some Chicago architecture! We’re grateful to be a part of this great institution and excited for the next decades to come in cancer care! #ASCO24 University of Chicago Hematology/Oncology

ASCO weekend this year means celebrating <a href="/UCCancerCenter/">UChicagoCancerCenter</a>’s 50th anniversary in style with some Chicago architecture! We’re grateful to be a part of this great institution and excited for the next decades to come in cancer care! #ASCO24 <a href="/UChicagoHemOnc/">University of Chicago Hematology/Oncology</a>
Barry Butler Photography (@barrybutler9) 's Twitter Profile Photo

Triple Strike at 1221am on Monday morning. Simultaneous lightning strikes on the Hancock, Trump Chicago and Sears Tower in Chicago. One image. #weather #news #ilwx #chicago #storm

Triple Strike at 1221am on Monday morning.  Simultaneous lightning strikes on the Hancock, Trump Chicago and Sears Tower in Chicago.  One image. #weather #news #ilwx #chicago #storm
Anand Patel (@anand_88_patel) 's Twitter Profile Photo

Our analysis of intensive chemo (IC) in CBF-AML (200 pt) is out in eJHaem Journal! Kudos to lead author Alexandra Rojek We found: -similar EFS/OS betw IC + GO & IC alone -longer 3y EFS w/ IC + KIT inhibitor (85%) we eagerly await NCT02013648 results! onlinelibrary.wiley.com/doi/10.1002/jh…

Our analysis of intensive chemo (IC) in CBF-AML (200 pt) is out in <a href="/e_JHaem/">eJHaem Journal</a>! Kudos to lead author <a href="/AlexandraRojek/">Alexandra Rojek</a> 

We found:
-similar EFS/OS betw IC + GO &amp; IC alone
-longer 3y EFS w/ IC + KIT inhibitor (85%)

we eagerly await NCT02013648 results!

onlinelibrary.wiley.com/doi/10.1002/jh…
Anand Patel (@anand_88_patel) 's Twitter Profile Photo

The final version of our eJHaem Journal paper on intensive chemo strategies in CBF-AML is available! Alexandra Rojek #leusm -3y OS 70% and 3y EFS 51% for entire cohort -IC + GO 3y EFS 50%, IC alone 3y EFS 47%, IC + KIT inhibitor 3y EFS 85% onlinelibrary.wiley.com/doi/10.1002/jh…

Kline Lab (@klinelabuchi) 's Twitter Profile Photo

We’re excited to see outstanding science talks at the Jonas Center for Cellular Therapy Symposium today University of Chicago Hematology/Oncology and updates on our lab’s work shared by Dr. Kline!

We’re excited to see outstanding science talks at the Jonas Center for Cellular Therapy Symposium today <a href="/UChicagoHemOnc/">University of Chicago Hematology/Oncology</a> and updates on our lab’s work shared by Dr. Kline!
University of Chicago Hematology/Oncology (@uchicagohemonc) 's Twitter Profile Photo

Congratulations to our Section Chief, Dr. Soni Smith MD new electee to the ASCO Board of Directors as the Designated Medical Oncologist!! We see her dedicated & positive leadership daily & know how deserving she is of this honor! More from ASCO at brnw.ch/21wPuRZ

Ajay Major, MD, MBA (@majorajay) 's Twitter Profile Photo

From Kline Lab in Blood Journal: multi-omic characterization of 4 'immune quadrants' in DLBCL, with better response to bispecifics (but not CAR-T) in "GCB Hot" versus "GCB Cold." #lymsm #tcellrx ashpublications.org/blood/article/…

From <a href="/KlineLabUChi/">Kline Lab</a> in <a href="/BloodJournal/">Blood Journal</a>: multi-omic characterization of 4 'immune quadrants' in DLBCL, with better response to bispecifics (but not CAR-T) in "GCB Hot" versus "GCB Cold." #lymsm #tcellrx ashpublications.org/blood/article/…
University of Chicago Hematology/Oncology (@uchicagohemonc) 's Twitter Profile Photo

ASCO ended over a week ago, but we're still thinking about how great it was! Highlights included: -Soni Smith MD's first ASCO conference on the Board of Directors -4 (!!) of our University of Chicago Hem/Onc Fellows winning YIAs -Rita Nanda as a FASCO recipient -30+ posters/presentations!

ASCO ended over a week ago, but we're still thinking about how great it was! Highlights included:
-<a href="/SoniSmithMD/">Soni Smith MD</a>'s first <a href="/ASCO/">ASCO</a> conference on the Board of Directors
-4 (!!) of our <a href="/UCHemOncFellows/">University of Chicago Hem/Onc Fellows</a> winning YIAs
-<a href="/RitaNandaMD/">Rita Nanda</a> as a FASCO recipient
-30+ posters/presentations!